MaxCyte (MXCT) Stock Highlights

3.49 | +4.8%

2024-11-21 04:46:39

MaxCyte Inc operates in the United States healthcare sector. It develops proprietary electroporation technology, which used blood cells instead of traditional chemical methods to transport medical gene therapies to targeted sites, increasing their safety and efficacy. The company technology finds its use in biotechnology and pharmaceutical firms engaged in cell therapy, including gene editing and immuno-oncology and in drug discovery, development, and biomanufacturing. Its products include MaxCyte STX, VLX, and GT. The company application includes Cell/Gene Therapy, Protein Production, Cell-based Assays, Gene Editing, Cell Line Development, and Viral Vectors/Vaccines. It acquires its income principally from the sale or lease of instruments and processing assemblies.

Statistics

Range Today

3.3 3.5

Volume Today 447.6K

Range 1 Year

3.16 5.55

Volume 1 Year 144.67M

Range 3 Year

2.45 12.69

Volume 3 Year 436.91M

Range 10 Year

2.45 17.44

Volume 10 Year 488.47M

Highlights

Market Capitalization 416.82M (small)

Floating Shares 96.33M

Current Price 3.49

Price To Earnings -10.45

Price To Revenue 4.84

Price To Book 1.67

Earnings Per Share -0.33

Payout Ratio 0%

Performance

Latest +4.8%

1 Month -7.43%

3 Months -18.27%

6 Months -25.11%

1 Year -15.9%

3 Years -72.5%

5 Years -79.46%

10 Years -79.46%

Benchmarks

Market Capitalization

36 / 58

Gross Profits

40 / 52

Total Revenue

46 / 57

Total Rank

20 / 58

Free Cashflow

44 / 56

Performance 5 years

47 / 58

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.